Mutamba Bark

Mutamba bark from Guazuma ulmifolia contains high concentrations of proanthocyanidins that inhibit angiotensin II binding at AT1 receptors and block cholera toxin-induced chloride secretion. These condensed tannins, particularly procyanidin B-2 and C-1, demonstrate antihypertensive, antidiarrheal, and protein kinase C inhibitory activities.

Origin & History

Mutamba Bark, sourced from *Guazuma ulmifolia*, is native to the tropical forests and savannas of Brazil, Mexico, and Peru. This traditional botanical is recognized for its rich bioactive compounds that support systemic detoxification and immune defense.

Historical & Cultural Context

Mutamba Bark (*Guazuma ulmifolia*) has been a cornerstone in Amazonian and Mesoamerican herbalism for centuries. Traditionally used for respiratory, immune, liver, and skin conditions, its applications are now being explored for antimicrobial, cardiovascular, and detoxifying effects.

Health Benefits

- **Supports liver detoxification**: by aiding in the elimination of toxins.
- **Enhances immune defense**: through its antimicrobial and immunomodulatory properties.
- **Improves circulation by**: supporting vascular integrity and blood flow.
- **Reduces inflammation via**: its rich content of anti-inflammatory compounds.
- **Nourishes skin and**: hair, promoting their health and vitality.
- **Promotes respiratory wellness**: by soothing the respiratory tract.

How It Works

Proanthocyanidins in mutamba bark, including procyanidin B-2 and C-1, inhibit [³H]-angiotensin II binding to human AT1 receptors, contributing to antihypertensive effects. These same compounds block cholera toxin-induced chloride secretion in rabbit colon tissue and inhibit protein kinase C activity. Additional phenolic compounds like epigallocatechin gallate (5.99 µg/mL in ethanolic extracts) provide antioxidant activity through DPPH and hydroxyl radical scavenging.

Scientific Research

Emerging research, including in vitro and animal studies, indicates Mutamba Bark's potential for antimicrobial, anti-inflammatory, and hepatoprotective effects. Further clinical studies are necessary to validate these traditional uses and determine optimal human dosages.

Clinical Summary

Current evidence for mutamba bark is limited to preclinical in vitro and animal studies, with no published human clinical trials documented in scientific literature. Laboratory studies show ethanolic bark extract at 40 µg/mL completely inhibited cholera toxin-induced secretion in rabbit colon models. Traditional use data indicates healers prescribe bark decoctions twice daily (97.2% oral administration) for dysentery and respiratory conditions. Quantified HPLC analysis confirms presence of bioactive phenolics, but human efficacy and optimal dosing require clinical validation.

Nutritional Profile

- Minerals: Magnesium, Potassium, Zinc
- Phytochemicals: Tannins, Flavonoids (quercetin, catechins), Ellagic acid, Proanthocyanidins, Plant sterols, Saponins, Bitter compounds

Preparation & Dosage

- Common forms: Decoctions, powdered extracts, tinctures, topical poultices, hair tonics.
- Dosage: 500–1000 mg powdered extract daily.
- Traditional application: Used in poultices for skin healing and as hair tonics.

Synergy & Pairings

Role: Bark botanical
Intention: Detox & Liver | Immune & Inflammation
Primary Pairings: - Turmeric (Curcuma longa)
- Ginger (Zingiber officinale)
- Ashwagandha (Withania somnifera)
- Camu Camu (Myrciaria dubia)

Safety & Interactions

Mutamba bark extracts demonstrate low toxicity in phytochemical screens, though comprehensive safety data is lacking. Proanthocyanidins may theoretically interact with AT1 receptor antagonists like losartan due to competitive receptor binding mechanisms. Tannin content could reduce absorption of alkaloid medications and peptide drugs when taken concurrently. Use should be avoided during pregnancy and lactation due to insufficient safety data, and cyanogenic heterosides present theoretical hydrogen cyanide risk at high doses.